Posted on

Nvidia launches new services for training large language models

As interest around large AI models — particularly large language models (LLMs) like OpenAI’s GPT-3 — grows, Nvidia is looking to cash in with new fully managed, cloud-powered services geared […]




Posted on

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines is touting […]




Posted on

Use the AWS Cloud for observational life sciences studies

In this post, we discuss how to use the AWS Cloud and its services to accelerate observational studies for life sciences customers. We provide a reference architecture for architects, business […]







Posted on

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has […]